Bharat Rasayan growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+5.9%+12.3%−15.4%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+13.9%+49.1%−40.6%
+16.8%+61.7%−46.6%
+3.4%+47.5%−23.4%
−74.1%+47.5%−23.4%
+1.7%+17.6%+11.5%
+12.8%+14.4%+10.6%
−23.3%+318.8%−80.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BHARATRAS₹948.20

Bharat Rasayan Limited

· Chemicals
₹ CrorePeersINSECTICIDIPLMOLGSPCROPPUNJABCHEMASTECBHAGCHEMNACLINDMcap ₹1,576 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—-15.4+12.3+5.9—
EBITDA Growth—-40.6+49.1+13.9—
EBIT Growth—-46.6+61.7+16.8—
Net Income Growth—-23.4+47.5+3.4—
EPS Growth—-23.4+47.5-74.1—
Total Assets Growth—+11.5+17.6+1.7—
Total Equity Growth—+10.6+14.4+12.8—
Cash from Operations Growth—-80.7+318.8-23.3—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.